manchestereveningnews.co.uk
Britain
USA
show
patient
experts
drug
Britain
USA
First new Alzheimer's drug in nearly 20 years approved by US regulators - despite experts’ concerns
Reading now: 515
manchestereveningnews.co.uk
manchestereveningnews.co.ukDon't miss a thing by getting the day's biggest stories sent direct to your inbox The first new drug for Alzheimer’s disease in nearly 20 years has been approved by regulators in the United States.
The US Food and Drug Administration has granted approval for the medicine made by American pharmaceutical firm Biogen. That's despite warnings from some experts that results of trials failed to prove it could slow progress of the disease.
The drug, Aducanumab, is given as an infusion every four weeks. It is the only drug that can likely treat the underlying disease, rather than manage symptoms like anxiety and insomnia according to regulators Stateside.
Read more on manchestereveningnews.co.uk
The website starsalert.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
Report this news
Related News
Celebrities
Locations